cgp 12177 has been researched along with Carcinoma, Anaplastic in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qing, F | 1 |
| Hayes, MJ | 1 |
| Rhodes, CG | 1 |
| Krausz, T | 1 |
| Fountain, SW | 1 |
| Burke, MM | 1 |
| Jones, T | 1 |
| Hughes, JM | 1 |
1 other study available for cgp 12177 and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Reduced beta adrenoceptor density in vivo in human lung tumours: a preliminary study with positron emission tomography.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Volume; Carcinoma; Cell Count; Humans; Lung; Lung Ne | 1996 |